Meeting of the Parliament 25 March 2014
There are indeed high uptake rates and we can be confident that there will be success in preventing instances of cervical cancer. HPV is implicated in a number of other cancers—oropharyngeal, penile and anal cancers. In particular, young men who have sex with men do not benefit from the herd immunity that young heterosexual men would benefit from. Is the Government actively considering the extension of the HPV vaccine to boys and young men? When can we expect to hear about some progress on that?